BeStock  
Stocks › Biotechnology › IONS

Ionis Pharmaceuticals IONS

US equityMarket cap rank #2142Biotechnology
$26.58 −$0.64 (-2.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.76 +0.68%
Open$26.93
Prev close$27.22
Day range$26.53 – $28.07
Volume3.19M
Market cap$4.43B
P/E (TTM)–
Dividend yield–

IONS Stock News

Headlines matching Ionis Pharmaceuticals or the IONS ticker, most recent first.

  • A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $84 to $104Market news · 9 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $61 to $115Market news · 5 Sep 2026 · Direct mention
  • CCORF Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $95Market news · 4 Sep 2026 · Direct mention
  • BMO Capital Downgrades Ionis Pharmaceuticals(IONS.US) to Hold Rating, Cuts Target Price to $61 NegativeMarket news · 4 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $115Market news · 4 Sep 2026 · Direct mention
  • CCORF Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $85Market news · 25 Sep 2026 · Direct mention
  • Oppenheimer Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $85 NegativeMarket news · 25 Sep 2026 · Direct mention
  • H.C. Wainwright Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $100Market news · 24 Sep 2026 · Direct mention
  • BMO Capital Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $54 NegativeMarket news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $84 to $100Market news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $70 to $100Market news · 23 Sep 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Maze Therapeutics, Inc. (MAZE) and Ionis Pharmaceuticals (IONS)TipRanks · 23 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $70 NegativeMarket news · 22 Sep 2026 · Direct mention
  • Barclays Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Maintains Target Price $85Market news · 18 Sep 2026 · Direct mention
  • Guggenheim Maintains Ionis Pharmaceuticals(IONS.US) With Buy Rating, Cuts Target Price to $80 NegativeMarket news · 15 Sep 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on IONS.

Sign in to join the discussion.

Scroll to Top